These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


140 related items for PubMed ID: 11805430

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The adjustment of 17-hydroxyprogesterone cut-off values for congenital adrenal hyperplasia neonatal screening by GSP according to gestational age and age at sampling.
    Jiang X, Tang F, Feng Y, Li B, Jia X, Tang C, Liu S, Huang Y.
    J Pediatr Endocrinol Metab; 2019 Nov 26; 32(11):1253-1258. PubMed ID: 31603856
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants.
    Nordenström A, Wedell A, Hagenfeldt L, Marcus C, Larsson A.
    Pediatrics; 2001 Oct 26; 108(4):E68. PubMed ID: 11581476
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cutoff levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight.
    van der Kamp HJ, Oudshoorn CG, Elvers BH, van Baarle M, Otten BJ, Wit JM, Verkerk PH.
    J Clin Endocrinol Metab; 2005 Jul 26; 90(7):3904-7. PubMed ID: 15797960
    [Abstract] [Full Text] [Related]

  • 15. [Measurement of 17 OH progesterone in blood in Chilean newborns: antecedents for implementing a grogram for the neonatal detection of congenital adrenal hyperplasia].
    Cattani A, Reyes ML, Azócar M, Soto J, Romeo E, Valdivia L, Poggi H, Foradori A.
    Rev Med Chil; 2000 Oct 26; 128(10):1113-8. PubMed ID: 11349510
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The influence of seasonality and manufacturer kit lot changes on 17α-hydroxyprogesterone measurements and referral rates of congenital adrenal hyperplasia in newborns.
    Pearce M, Dauerer E, DiRienzo AG, Caggana M, Tavakoli NP.
    Eur J Pediatr; 2017 Jan 26; 176(1):121-129. PubMed ID: 27900477
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Neonatal screening for congenital adrenal hyperplasia.
    Barra CB, Silva IN, Pezzuti IL, Januário JN.
    Rev Assoc Med Bras (1992); 2012 Jan 26; 58(4):459-64. PubMed ID: 22930025
    [Abstract] [Full Text] [Related]

  • 20. Screening for congenital adrenal hyperplasia: the Delfia Screening Test overestimates serum 17-hydroxyprogesterone in preterm infants.
    al Saedi S, Dean H, Dent W, Stockl E, Cronin C.
    Pediatrics; 1996 Jan 26; 97(1):100-2. PubMed ID: 8545200
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.